SEARCH

SEARCH BY CITATION

References

  • 1
    Smith W, Assink J, Klein Ret al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001: 108: 697704.
  • 2
    Friedman DS, O'Colmain BJ, Munoz B et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004: 122: 564572.
  • 3
    Ferris FL, Davis MD, Clemons TE et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005: 123: 15701574.
  • 4
    Chakravarthy U, Wong TY, Fletcher A et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 2010: 10: 31.
  • 5
    Klein R, Peto T, Bird A, Vannewkirk, MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004: 137: 486495.
  • 6
    Klein R, Klein BE, Knudtson MD et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006: 113: 373380.
  • 7
    Clemons TE, Milton RC, Klein R et al. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005: 112: 533539.
  • 8
    Munch IC, Linneberg A, Larsen M. Precursors of age-related macular degeneration: associations with physical activity, obesity and serum lipids in the Inter99 Eye Study. Invest Ophthalmol Vis Sci 2013: 54 (6): 39323940.
  • 9
    Kabasawa S, Mori K, Horie-Inoue K et al. Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology 2011: 118: 10821088.
  • 10
    Spencer KL, Olson LM, Schnetz-Boutaud N et al. Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration. PLoS One 2011: 6: e17784.
  • 11
    Iyengar SK, Song D, Klein BE et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 2004: 74: 2039.
  • 12
    Klein ML, Schultz DW, Edwards A et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 1998: 116: 10821088.
  • 13
    Weeks DE, Conley YP, Tsai HJ et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 2004: 75: 174189.
  • 14
    Abecasis GR, Yashar BM, Zhao Y et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 2004: 74: 482494.
  • 15
    Edwards AO, Ritter R 3rd, Abel KJ et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005: 308: 421424.
  • 16
    Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005: 308: 419421.
  • 17
    Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005: 308: 385389.
  • 18
    Zareparsi S, Branham KE, Li M et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005: 77: 149153.
  • 19
    Li M, Atmaca-Sonmez P, Othman M et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 2006: 38: 10491054.
  • 20
    Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007: 39: 12001201.
  • 21
    Yates JR, Sepp T, Matharu BK et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007: 357: 553561.
  • 22
    Gold B, Merriam JE, Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006: 38: 458462.
  • 23
    Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 2009: 17: 100104.
  • 24
    Dewan A, Liu M, Hartman S et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006: 314: 989992.
  • 25
    Rivera A, Fisher SA, Fritsche LG et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005: 14: 32273236.
  • 26
    Kanda A, Chen W, Othman M et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007: 104: 1622716232.
  • 27
    Chen W, Stambolian D, Edwards AO et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010: 107: 74017406.
  • 28
    Neale BM, Fagerness J, Reynolds R et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010: 107: 73957400.
  • 29
    Yu Y, Bhangale TR, Fagerness J et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 2011: 20: 36993709.
  • 30
    Arakawa S, Takahashi A, Ashikawa K et al. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet 2011: 43: 10011004.
  • 31
    Klaver CC, Kliffen M, van Duijn CM et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998: 63: 200206.
  • 32
    McKay GJ, Patterson CC, Chakravarthy U et al. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat 2011: 32: 14071416.
  • 33
    Zareparsi S, Reddick AC, Branham KE et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 2004: 45: 13061310.
  • 34
    The AMD Gene Consortium, Fritsche LG, Chen W et al. Seven new loci associated with age-related macular degeneration. Nat Genet 2013: 45: 433439.
  • 35
    Gorin MB. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med 2012: 33: 467486.
  • 36
    Priya RR, Chew EY, Swaroop A. Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology 2012: 119: 25262536.
  • 37
    Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009: 10: 1943.
  • 38
    Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001: 119: 14171436.
  • 39
    Chew EY, Clemons TE, Agron E et al. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS Report No. 35. Ophthalmology 2013. Apr 10. DOI:pii: S0161-6420(13)00036-5.10.1016/j.ophtha.2013.01.021. [Epub ahead of print]
  • 40
    SanGiovanni JP, Agron E, Clemons TE, Chew EY. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol 2009: 127: 110112.
  • 41
    Sangiovanni JP, Agron E, Meleth AD et al. {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr 2009: 90: 16011607.
  • 42
    SanGiovanni JP, Chew EY, Agron E et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008: 126: 12741279.
  • 43
    Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013: 309: 20052015.
  • 44
    Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002: 134: 411431.
  • 45
    Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996: 122: 393403.
  • 46
    Ho L, van Leeuwen R, Witteman JC et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 2011: 129: 758766.
  • 47
    Schaumberg DA, Hankinson SE, Guo Q et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007: 125: 5562.
  • 48
    Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 2009: 5: e1000337.
  • 49
    Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BH. Modelling the genetic risk in age-related macular degeneration. PLoS One 2012: 7: e37979.
  • 50
    van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA 2005: 293: 15091513.
  • 51
    CATT research Group, Martin DF, Maguire MG et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011: 364: 18971908.
  • 52
    Rosenfeld PJ, Brown DM, Heier JS et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006: 355: 14191431.
  • 53
    Brantley MA Jr, Fang AM, King JM et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 2007: 114: 21682173.
  • 54
    Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA Jr. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Br J Ophthalmol 2009: 93: 610613.
  • 55
    McKibbin M, Ali M, Bansal S et al. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Br J Ophthalmol 2012: 96 (2): 208.
  • 56
    Klein ML, Francis PJ, Rosner B et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 2008: 115: 10191025.
  • 57
    Gorin MB. A clinician's view of the molecular genetics of age-related maculopathy. Arch Ophthalmol 2007: 125: 2129.
  • 58
    Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 2009: 461: 747753.
  • 59
    Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010: 11: 3146.
  • 60
    Priya RR, Rajasimha HK, Brooks MJ, Swaroop A. Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery. Methods Mol Biol 2012: 884: 335351.
  • 61
    Bamshad MJ, Ng SB, Bigham AW et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011: 12: 745755.
  • 62
    Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet 2011: 13: 135145.
  • 63
    Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008: 40: 695701.
  • 64
    Raychaudhuri S, Iartchouk O, Chin K et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 2011: 43: 12321236.
  • 65
    van de Ven JP, Nilsson SC, Tan PL et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet 2013: May 19. DOI: 10.1038/ng.2640. [Epub ahead of print]
  • 66
    Do R, Kathiresan S, Abecasis GR. Exome sequencing and complex disease: practical aspects of rare variant association studies. Hum Mol Genet 2012: 21: R1R9.
  • 67
    Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994: 8: 352356.
  • 68
    Allikmets R, Singh N, Sun H et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997: 15: 236246.
  • 69
    Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000: 67: 487491.
  • 70
    1000 Genome Project Consortium, Abecasis GR, Auton A et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012: 491: 5665.
  • 71
    Fu W, O'Connor TD, Jun G et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013: 493: 216220.